These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33486897)

  • 1. Generalized neurocognitive impairment in individuals at ultra-high risk for psychosis: The possible key role of slowed processing speed.
    Randers L; Jepsen JRM; Fagerlund B; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Brain Behav; 2021 Mar; 11(3):e01962. PubMed ID: 33486897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognition and social cognition in youth and young adults at ultra-high-risk for psychosis and bipolar disorder.
    Bora E; Eyuboglu MS; Cesim E; Demir M; Yalincetin B; Ermis C; Özbek Uzman S; Sut E; Demirlek C; Verim B; Baykara B; Akay A; İnal N; Akdede BB
    Schizophr Res; 2024 Apr; 266():58-65. PubMed ID: 38368706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study.
    Randers L; Jepsen JRM; Fagerlund B; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Aug; 290():112969. PubMed ID: 32450415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
    Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social cognition and neurocognition in first-episode bipolar disorder and psychosis: The effect of negative and attenuated positive symptoms.
    Bora E; Eyuboglu MS; Cesim E; Demir M; Yalincetin B; Ermis C; Özbek Uzman S; Sut E; Demirlek C; Verim B; Baykara B; İnal N; Akdede BB
    J Affect Disord; 2024 Apr; 351():356-363. PubMed ID: 38290586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
    Mallawaarachchi SR; Amminger GP; Farhall J; Bolt LK; Nelson B; Yuen HP; McGorry PD; Markulev C; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2020 Apr; 218():48-54. PubMed ID: 32171637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms.
    Anda L; Brønnick KK; Johannessen JO; Joa I; Kroken RA; Johnsen E; Rettenbacher M; Fathian F; Løberg EM
    Front Psychiatry; 2019; 10():695. PubMed ID: 31632305
    [No Abstract]   [Full Text] [Related]  

  • 12. General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.
    Hur JW; Byun MS; Shin NY; Shin YS; Kim SN; Jang JH; Kwon JS
    Schizophr Res; 2013 Sep; 149(1-3):83-7. PubMed ID: 23810120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive profiles in help-seeking individuals: comparison of risk for psychosis and bipolar disorder criteria.
    Metzler S; Dvorsky D; Wyss C; Müller M; Traber-Walker N; Walitza S; Theodoridou A; Rössler W; Heekeren K
    Psychol Med; 2014 Dec; 44(16):3543-55. PubMed ID: 25066246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of smoking Behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study.
    van der Heijden HS; Schirmbeck F; Kempton MJ; van der Gaag M; Allott K; Nelson B; Ruhrmann S; de Haan L; Vermeulen JM;
    Eur Psychiatry; 2021 Sep; 64(1):e60. PubMed ID: 34544507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis.
    He Q; Jantac Mam-Lam-Fook C; Chaignaud J; Danset-Alexandre C; Iftimovici A; Gradels Hauguel J; Houle G; Liao C; ; Dion PA; Rouleau GA; Kebir O; Krebs MO; Chaumette B
    Transl Psychiatry; 2021 Oct; 11(1):518. PubMed ID: 34628483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms.
    Randers L; Fagerlund B; Jepsen JRM; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Dec; 294():113498. PubMed ID: 33157481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group.
    Simonsen C; Sundet K; Vaskinn A; Birkenaes AB; Engh JA; Faerden A; Jónsdóttir H; Ringen PA; Opjordsmoen S; Melle I; Friis S; Andreassen OA
    Schizophr Bull; 2011 Jan; 37(1):73-83. PubMed ID: 19443616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.